Harini Bupathi, Esq, joins to discuss the impacts of PBM network terminations and how pharmacies can recover financially.
|Articles|May 15, 2006
CMS posts Pharmacy Quality Alliance phone call
Due to high demand for a replay, CMS has made available a recordingto its recent pharmacy open door forum on the Pharmacy QualityAlliance. The on-line audio of the telephone conference call can beaccessed at www.cms.gov/pharmacy.
Advertisement
Advertisement
Related to this article
Pharmacists expand access with no-appointment care but face state laws limiting test-to-treat for COVID-19 and flu, fueling calls for advocacy.
AJ Barbarito, Esq, provides nuance to the evolving pharmacy reimbursement landscape and how PBMs and pharmacies alike are adapting as they approach 2027.
Nicole Pezzino, PharmD, BCACP, BC-ADM, CDCES, details how pharmacies can utilize the booming GLP-1 medication class for greater revenue opportunities.
Matt Martin, PharmD, BCSCP, explores current developments in the peptide space and what pharmacists need to know amid FDA decision-making processes.
This new, nonprescription therapy expands eye relief options for patients in need of apraclonidine eye drop formulations.
Cheri Schmit explains how pharmacists' roles are growing beyond dispensing into prevention, test-and-treat, and artificial intelligence-supported patient care.
In celebration of American Pharmacists Month, Melissa McGivney, PharmD, FAPhA, FCCP, provides a snapshot of where the profession has come and where it still has to go.
Advertisement
Advertisement
Trending on Drug Topics
1
PBM Underpayment Persists as Cost-Plus Brings New Strain | NCPA 2026
2
FAQ: Scaling Pharmacy Services Through GLP-1 Care | NCPA 2026
3
Pharmacists Must Guide Peptide Talks Pending FDA Action | NCPA 2026
4
FDA Approves Brytly for OTC Eye Redness Relief
5